Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
This study has been completed.
Study NCT00467610   Information provided by Rush University Medical Center

First Received on April 26, 2007.   Last Updated on February 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myelodysplastic Syndrome
Additional conditions recognized in this trial
Myelodysplastic Syndromes
Preleukemia
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Neoplasms
Precancerous Conditions
Interventions listed in this trial
Panhematin
Sponsors listed in this trial
Rush University Medical Center
H. Lundbeck A/S


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services